InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,513.37
(
-0.56%
)
US TECH 100
19,026.80
(
-0.80%
)
Dow Jones
40,311.05
(
-0.87%
)
Brent Oil
81.98
(
-2.50%
)
Bitcoin
66,676.36
(
4.23%
)
Post# of 252640
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120080
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 144021

Wednesday, 06/20/2012 3:52:33 PM

Wednesday, June 20, 2012 3:52:33 PM

Post# of 252640
FDA advisory panel votes 14-1 against SNY’s Semuloparin anticoagulant as a prophylactic for chemotherapy patients:

http://online.wsj.com/article/SB10001424052702304898704577478600549029584.html

Hard to believe that SNY once touted this drug as the replacement for Lovenox; see #msg-76717361 for background.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up